Maple Securities USA’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
BIT
BFA
Maple Securities USA's AMGN Position: Q2 2015 in Review
Maple Securities USA sold out of Amgen (AMGN) in Q2 2015, closing a stake of 3,706 shares — an estimated $592K sold.
Maple Securities USA first reported a position in AMGN in Q2 2013 and held it in 4 quarters. The position peaked at $6.19M in Q3 2013. 1,366 funds tracked by Wall St. Rank hold AMGN as of Q2 2015.
- Maple Securities USA reported no remaining Amgen position as of Q2 2015 after selling out during the quarter.
- Maple Securities USA sold 3,706 Amgen shares in Q2 2015, an estimated $592K.
- Maple Securities USA first reported a position in Amgen in Q2 2013 and held it in 4 quarters.
- Maple Securities USA's Amgen position peaked at $6.19M in Q3 2013.
- 1,366 funds tracked by Wall St. Rank held Amgen as of Q2 2015.
Based on Maple Securities USA's 13F filing for Q2 2015, filed 24 Jul 2015.